Waters Corporation

NYSE WAT

Download Data

Waters Corporation Gross Working Capital for the year ending December 31, 2023: USD 885.46 M

Waters Corporation Gross Working Capital is USD 885.46 M for the year ending December 31, 2023, a 10.98% change year over year. Gross working capital is a financial metric that represents the amount of a company's current assets available to cover its current liabilities and short-term debt obligations. It is calculated by subtracting the sum of current liabilities and short-term debt from the total current assets of a company. Gross working capital provides insights into a company's short-term liquidity and its ability to meet its financial obligations in the near future.
  • Waters Corporation Gross Working Capital for the year ending December 31, 2022 was USD 797.83 M, a -3.83% change year over year.
  • Waters Corporation Gross Working Capital for the year ending December 31, 2021 was USD 829.61 M, a 145.45% change year over year.
  • Waters Corporation Gross Working Capital for the year ending December 31, 2020 was USD 338.00 M, a 115.97% change year over year.
  • Waters Corporation Gross Working Capital for the year ending December 31, 2019 was USD -2.12 B, a -809.39% change year over year.
NYSE: WAT

Waters Corporation

CEO Dr. Udit Batra Ph.D.
IPO Date Nov. 16, 1995
Location United States
Headquarters 34 Maple Street, Milford, MA, United States, 01757
Employees 7,900
Sector Healthcare
Industry Diagnostics & research
Description

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Similar companies

IDXX

IDEXX Laboratories Inc

NA

NA

CRL

Charles River Laboratories

NA

NA

RVTY

Revvity Inc.

NA

NA

DHR

Danaher Corporation

NA

NA

TWST

Twist Bioscience Corp

NA

NA

ICLR

ICON PLC

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email